Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q1 2022 Earnings

5MayExpected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
-26
-17.17
-8.33
0.5

Details

Expected EPS
-15
Actual EPS
-14.5
Surprise EPS
0.5
Surprise Percent
+3.33%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -14.5 per share for Q1 2022.

0 Comments

Share your thoughts